SHREVEPORT, La. (KSLA) - Parkinson’s disease is a progressive disorder that affects the nervous system and the parts of the ...
Veronica Brown lived with chronic fatigue, depression, and anxiety for over 10 years before she learned they were early signs ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
A drug trial underway at Macquarie University is taking advantage of an early warning sign of Parkinson's in the hope of ...
Nielsen, Jr., Research Professor of Parkinson's Disease and Movement Disorders, have defined new biologic and clinical ...
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
is conducting a Phase III trial to see whether a small molecule known as buntanetap can inhibit the formation of toxic alpha-synuclein clumps in the brains of early-stage Parkinson’s patients.
Today, the technique remains the clinical standard for advanced stages of Parkinson’s and has benefitted more than 150,000 patients worldwide. In 2021, the French-Algerian neurosurgeon has been ...
Diagnosing Parkinson's in the earliest stages before symptoms become serious is a major challenge in medicine, and digital health company PreciseDx thinks it may have a solution to the problem.